NCT04981171

Brief Summary

This prospective trial will be a single-center, participant-blinded, randomized controlled trial. It is reported in previous studies that both acupuncture and transcutaneous electrical nerve stimulation are effective in reducing neck pain comparing to placebo or exercise. Taking into account the convenience of electro-thumbtack needle therapy shown in clinical practice, this study aims to evaluate the efficacy and safety of electro-thumbtack needle therapy for alleviating chronic neck pain compared with sham electro-thumbtack needle therapy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 28, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

April 3, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

1.7 years

First QC Date

July 18, 2021

Last Update Submit

March 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of participants with an at least 50% decrease in NRS-NP from baseline.

    Rate pain intensity by 11 numbers from 0 (no pain at all) to 10 (worst pain imaginable)

    week 4

Secondary Outcomes (8)

  • Change of NRS-NP from baseline.

    week 4, 16, 28

  • Proportion of participants with an at least 50% decrease in NRS-NP from baseline.

    week 16, 28

  • Proportion of participants with an at least 30% decrease in NRS-NP from baseline.

    week 4, 16, 28

  • Change of NPQ from baseline.

    week 4, 16, 28

  • Proportion of participants with an at least 25% decrease in NPQ from baseline and a "better" or "much better" for global effectiveness rating.

    week 4, 16, 28

  • +3 more secondary outcomes

Other Outcomes (5)

  • Self-expectation assessment.

    baseline

  • Preference of ETN assessment.

    baseline

  • Blinding assessment.

    week 4

  • +2 more other outcomes

Study Arms (2)

Electro-thumbtack Needle Therapy (ETN) group

EXPERIMENTAL

Electro-thumbtack needles (0.25×2 mm) will be inserted into acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, turn on the device to produce a proper electric stimulation that the participant can tolerate.

Procedure: Electro-thumbtack Needle Therapy

Sham Electro-thumbtack Needle Therapy (ETN) group

SHAM COMPARATOR

Sham electro-thumbtack needles (0.25×0.2 mm) which are specially produced have blunt tips instead of sharp needle tip. They will be taped on acupoints of Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) after sterilization. Then apply the gel electrodes and stimulation devices, produce a minimal level of electric stimulation for 30 seconds before turning off the device.

Procedure: Sham electro-thumbtack needle therapy

Interventions

Each treatment session starts with sterilizing acupoints. Dazhui (GV14), bilateral Wangu (GB12), bilateral cervical Jiaji (at C4 and C6 level), two Ashi points and bilateral Houxi (SI3) have been selected in accordance with the principle of acupuncture prescription making and the consensus of experts on treating neck pain. Electro-thumbtack needles (0.25×2 mm) will be held by the acupuncturist between thumb and forefinger, vertically inserted into skin instantly and taped well on skin. Then assemble the gel electrodes to the surface of the conductive adhesive tape, also assemble the portable stimulation devices, adjust the current intensity from level 1 to a proper level that the participant can tolerate. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.

Also known as: ETN
Electro-thumbtack Needle Therapy (ETN) group

Each treatment session starts with sterilizing acupoints. Sham electro-thumbtack needles (0.25×0.2 mm) will be held by the acupuncturist between thumb and forefinger, taped well on skin without penetration. The adhesive tape of needles are also produced with conductive material, after assembling the gel electrodes and the portable stimulation devices, adjust the current intensity to level 1 for a minimal stimulus which will last for only 30 seconds. By this time the acupuncturist will turn the device off to cut the current. Participants will receive three 30-min treatment sessions per week every other day for 4 consecutive weeks.

Also known as: Sham ETN
Sham Electro-thumbtack Needle Therapy (ETN) group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with neck pain with headaches or neck pain with movement coordination impairments according to the Orthopaedic Section of the American Physical Therapy Association (APTA);
  • Aaged 18-65 years;
  • History of neck pain for at least 3 months;
  • A score of ≥4 in Numerical Rating Scale for neck pain (NRS-NP) assessing the average neck pain intensity over last 7 days until the day of recruitment.

You may not qualify if:

  • Diagnosed with neck pain with mobility deficits or neck pain with radiating pain according to the Orthopaedic Section, APTA;
  • Known specific reason leading to neck pain such as tumor, immune disease, endocrine and metabolic disorders, neurological abnormalities, cervical vertebra fracture, cervical dislocation;
  • Acute neck pain or neck pain with radiating pain or upper limb symptoms;
  • Neck pain with sensory or motor disturbance;
  • Prior cervical spine surgery or congenital abnormalities;
  • Experiencing medical dispute litigation;
  • Have received acupuncture in last 30 days;
  • In need of analgesic, muscle relaxant, hormones, or bearing greater pain from another area;
  • Allergic to metal or adhesive tape, or carrying cardiac pacemaker, or skin damaged at selected acupoints;
  • Disable to communicate or critically ill;
  • Drug or alcohol dependent;
  • Currently or planning to be pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Shi H, Wang X, Yan Y, Zhu L, Chen Y, Gao S, Liu Z. Efficacy and Safety of Electro-Thumbtack Needle Therapy for Patients With Chronic Neck Pain: Protocol for a Randomized, Sham-Controlled Trial. Front Med (Lausanne). 2022 Apr 29;9:872362. doi: 10.3389/fmed.2022.872362. eCollection 2022.

MeSH Terms

Conditions

Neck Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hangyu Shi

    Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2021

First Posted

July 28, 2021

Study Start

April 3, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

March 31, 2022

Record last verified: 2022-03